Aspirin/Vonoprazan Fumarate

阿司匹林/富马酸伏诺拉生

Report date: 2026/01/13 14:23:46

Base Information

Drug NameAspirin/Vonoprazan Fumarate
Drug Alias NameCABPIRINTAK-438ASA
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsPotassium-transporting ATPase inhibitors
TargetsPotassium-transporting ATPaseCyclooxygenases
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsThromboembolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2020/03/25
Country/TerritoryJapan
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsThromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A